论文信息 - 90Yttrium Ibritumomab Tiuxetan as First Line Treatment for Follicular Lymphoma. First Results from an International Phase II Clinical Trial - 字舞流文

90Yttrium Ibritumomab Tiuxetan as First Line Treatment for Follicular Lymphoma. First Results from an International Phase II Clinical Trial

C. Pott | O. Lindén | G. Hess | B. Frericks | A. Pinto | W. Linkesch | A. Viardot | U. Keller | F. Frigeri | M. Arcamone | C. Scholz | K. Lerch | Antonto Puzzutto